Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kouyanqing Pian (口炎清片) is an approved traditional Chinese medicine (TCM) tablet developed and manufactured by Zhejiang Kangde Pharmaceutical. It is primarily indicated for the treatment of oral inflammation and stomatitis. The formulation is based on TCM principles, typically aimed at clearing heat, nourishing yin, and detoxifying the oral cavity. While the specific herbal composition for Zhejiang Kangde's version is not explicitly detailed in the provided pipeline information, Kouyanqing is a recognized TCM formula often used for recurrent aphthous stomatitis and other inflammatory conditions of the mouth. It is administered orally and is part of the company's established portfolio of TCM products.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kouyanqing Pian.